RVP vs STVN vs SKYA Stock Comparison

Retractable Technologies, Stevanato Group S.p.A and SkyAI Prices as of Nov 5, 2026 Peers: Industry group
1 more company in this comparison (BAX) Create a free account to keep reading and compare up to 10 companies.
STVN Stevanato Group S.p.A.
$13.18 -33.6% 1M -47.3% 1Y
Market cap
$3.62B
P/E
22.2x
Revenue (TTM)
$1.45B
Div. yield
–
Medical Supplies Healthcare
6 wins
SKYA SkyAI, Inc.
$2.92 +55.3% 1M -30.6% 1Y
Market cap
$211.23M
P/E
–
Revenue (TTM)
$174.18K
Div. yield
–
Medical Supplies Healthcare
3 wins

Head to Head

10 decided of 12

Stevanato Group S.p.A leads on 6 of the 12 questions below (Stevanato Group S.p.A 6, SkyAI 3, Retractable Technologies 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionRVPSTVNSKYALeader
Larger companyMarket capitalisation $17.06M $3.62B $211.23M STVN
Cheaper on earningsLower P/E, profitable companies only -4.7x 22.2x -0.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 20.0x 0.0x SKYA
Faster revenue growthRevenue growth, trailing twelve months -11.2% +12.0% +108.0% SKYA
More profitableNet margin, trailing twelve months -10.6% 11.2% -228,220.7% STVN
Better return on capitalReturn on invested capital -31.4% 8.2% — STVN
Less leveragedLower net debt / EBITDA 2.6x 1.1x — STVN
Higher dividend yieldTrailing dividend yield — 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -33.5% -47.3% -30.6% SKYA
Better 5-year returnAnnualised price return, 5 years -42.5%/yr -11.5%/yr — STVN
Less volatileAnnualised volatility, 1 year 39.9% 57.3% 104.7% RVP
Higher overall scoreMean of the five percentile scores vs peers 53/100 68/100 27/100 STVN

Percentile Scorecard

RVPSTVNSKYA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisRVPSTVNSKYA
Valuation 73 #63 of 229 95 #12 of 229 4 #221 of 229
Growth 35 #145 of 221 41 #131 of 221 4 #213 of 221
Profitability 37 #132 of 210 83 #37 of 210 1 #209 of 210
Financial Health 66 #82 of 240 75 #61 of 240 95 #13 of 240
Shareholder Returns – 49 #76 of 147 33 #99 of 147
Overall 53 68 27
  • RVP ranked among 247 companies in Medical Devices and Diagnostics
  • STVN ranked among 247 companies in Medical Devices and Diagnostics
  • SKYA ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodRVPSTVNSKYASPY
1 month -16.2%-33.6%+55.3% -5.9%
3 months -14.9%-35.0%+149.6% -4.6%
6 months -19.1%-26.9%+56.1% +0.2%
Year to date -26.2%-34.5%+43.8% +7.5%
1 year -33.5%-47.3%-30.6% +8.2%
3 years -47.2%-51.3%-99.9% +68.3%
3 years, per year -19.2%-21.3%-90.0% +19.0%
5 years -93.7%-45.8%— +56.5%
5 years, per year -42.5%-11.5%— +9.4%
10 years -77.6%—— +251.5%
10 years, per year -13.9%—— +13.4%

Risk

MeasureRVPSTVNSKYASPY
Volatility, 1Y 39.9%57.3%104.7% 13.6%
Downside volatility, 1Y 44.3%65.4%104.1% 14.2%
Beta vs S&P 500, 1Y 0.110.922.15 1.00
Return / volatility, 1Y -0.84-0.83-0.29 0.60
Max drawdown, 5Y -94.0%-62.9%-100.0% -25.4%
From 52-week high -33.5%-47.3%-30.6% -5.9%
52-week high $0.86$25.00$4.21 $779.14
52-week low $0.56$13.18$0.95 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleRVPSTVNSKYA
P/E now vs peer median -4.7xmedian 26.9x 22.1xmedian 26.9x -0.5xmedian 26.9x
P/S now vs peer median 0.5xmedian 2.9x 2.8xmedian 2.9x 1,209xmedian 2.9x
EV/EBITDA now vs peer median 1.5xmedian 17.5x 12.3xmedian 17.5x -0.5xmedian 17.5x
P/FCF now vs peer median -3.3xmedian 26.4x 6.8xmedian 26.4x -1.0xmedian 26.4x
P/B now vs peer median 0.2xmedian 2.3x 2.2xmedian 2.3x 1.3xmedian 2.3x
PEG now vs peer median 0.22median 0.88 -608.35median 0.88 0.01median 0.88

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsRVPSTVNSKYA
Revenue $33.90M $1.45B $174.18K
Gross profit -$491.51K $422.60M $324.68K
Operating income -$22.68M $241.76M -$374.36M
Net income -$3.37M $163.03M -$397.51M
Free cash flow -$5.11M $588.03M -$201.93M
R&D $682.03K $27.87M $475.55K
EPS (diluted) $-0.12 $0.60 $-5.51
Cash & equivalents $2.64M $130.31M $12.07M
Total debt $715.92K $537.00M –
Shares (diluted) 29.94M 272.96M 72.09M
Enterprise value -$129.34M $3.15B $165.94M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricRVPSTVNSKYA
P/E -4.7x 22.1x -0.5x
P/FCF -3.3x 6.8x -1.0x
P/Operating cash flow -3.4x 13.2x -14.6x
P/S 0.5x 2.8x 1,209x
P/B 0.2x 2.2x 1.3x
P/Tangible book 0.2x 2.3x 16.2x
EV/EBITDA 1.5x 12.3x -0.5x
EV/EBIT 1.0x 18.1x -0.5x
EV/Revenue -0.7x 3.0x 1,139x
EV/FCF 4.3x 7.5x -1.0x
EV/Operating cash flow 4.5x 14.6x -13.8x
PEG (3Y EPS CAGR) 0.22 -608.35 0.01

Growth

14 metrics
MetricRVPSTVNSKYA
Revenue growth (1Y) -11.2% 12.0% 108.0%
Revenue CAGR (3Y) -14.7% 8.8% 19.4%
Gross profit growth (1Y) 81.2% 13.9% –
Gross profit CAGR (3Y) -26.8% 5.5% –
Operating income growth (1Y) -2.3% 11.8% -8,055%
Operating income CAGR (3Y) -11.7% 4.4% -240.7%
Net income growth (1Y) 61.4% 5.0% -54,854%
Net income CAGR (3Y) -23.9% 1.0% -268.2%
EPS growth (1Y) 59.8% 4.3% -658.6%
EPS CAGR (3Y) -21.9% 0.0% -100.6%
Operating cash flow growth (1Y) 58.8% 16.9% -356.8%
Operating cash flow CAGR (3Y) -16.8% 22.5% -24.4%
Free cash flow growth (1Y) 62.3% 7.7% -6,031%
Free cash flow CAGR (3Y) 20.0% -1.4% -196.9%

Profitability

14 metrics
MetricRVPSTVNSKYA
Gross margin -1.4% 29.1% 186.4%
EBITDA margin -43.9% 24.6% -214,892%
Operating margin -66.9% 16.7% -214,931%
Pretax margin -9.9% 16.2% -221,236%
Net margin -10.6% 11.2% -228,221%
FCF margin -15.1% 40.6% -115,934%
Operating cash flow margin -14.6% 20.8% -8,259%
Return on equity -4.7% 9.1% -280.7%
Return on assets -2.4% 5.4% -276.3%
Return on invested capital -31.4% 8.2% –
Return on capital employed -18.0% – -223.1%
Asset turnover 0.2x 0.5x 0.0x
Cash conversion (OCF / net income) 1.5x 1.8x 0.0x
Stock comp / revenue – – 52,451%

Financial Health

11 metrics
MetricRVPSTVNSKYA
Debt / assets 0.5% 17.7% –
Debt / equity 0.0x 0.3x –
Net debt / EBITDA 2.6x 1.1x –
Debt / FCF -0.1x 0.9x –
Liabilities / assets 48.6% 40.2% 1.9%
Equity / assets 51.4% 59.8% 98.1%
Interest coverage -278.8x 17.3x –
Current ratio 4.9x – 5.3x
Quick ratio 3.7x – 4.4x
Cash ratio 3.0x – 4.2x
Altman Z-score 0.43 – 29.80

Shareholder Returns

7 metrics
MetricRVPSTVNSKYA
Dividend yield – 0.4% –
Net buyback yield – – -0.6%
Shareholder yield – 0.4% -0.6%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusRVPSTVNSKYA
Forward P/E – 20.0xFY2026 0.0xFY2026
EPS, next fiscal year – $0.66FY2026 $2,362.06FY2026
EPS growth, next FY – +4.8%FY2026 –
EPS growth, the year after – +10.6% –
Revenue, next fiscal year – $1.46BFY2026 $70.01MFY2026
Revenue growth, next FY – +5.1%FY2026 +34,200.1%FY2026
Revenue growth, the year after – +7.2% +17.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersRVPSTVNSKYA
Held by institutions 8.8% 16.4% –
Institutions holding 32 126 –
Change in shares held, QoQ +5.9% +0.4% –
Institutions buying 10 61 –
Institutions selling 4 52 –
Buyers to sellers 2.50 1.17 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

RVPSTVNSKYA
RVP 1.00 0.07 0.03
STVN 0.07 1.00 0.09
SKYA 0.03 0.09 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, RVP, STVN and SKYA?

Stevanato Group S.p.A (STVN) is the largest by market capitalisation: Retractable Technologies (RVP) $17.06M, Stevanato Group S.p.A (STVN) $3.62B, SkyAI (SKYA) $211.23M.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: Retractable Technologies (RVP) -11.2%, Stevanato Group S.p.A (STVN) +12.0%, SkyAI (SKYA) +108.0%.

Which company is more profitable?

Stevanato Group S.p.A (STVN) has the highest net margin (Retractable Technologies (RVP) -10.6%, Stevanato Group S.p.A (STVN) 11.2%, SkyAI (SKYA) -228,220.7%). On return on invested capital, Stevanato Group S.p.A (STVN) leads (Retractable Technologies (RVP) -31.4%, Stevanato Group S.p.A (STVN) 8.2%).

Which stock has performed better?

Over the past year SkyAI (SKYA) returned the most: Retractable Technologies (RVP) -33.5%, Stevanato Group S.p.A (STVN) -47.3%, SkyAI (SKYA) -30.6%. Over five years, Stevanato Group S.p.A (STVN) compounded fastest (Retractable Technologies (RVP) -42.5%/yr, Stevanato Group S.p.A (STVN) -11.5%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Retractable Technologies (RVP) has been the steadiest (Retractable Technologies (RVP) 39.9%, Stevanato Group S.p.A (STVN) 57.3%, SkyAI (SKYA) 104.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, RVP, STVN and SKYA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Stevanato Group S.p.A (STVN) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.